Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in GermanyPeter Mohr, Michael Weichenthal, Chalid Assaf et al.|Cancers|2022Cited by 13